(109 days)
No
The description focuses on the chemical composition and physical properties of a dental adhesive resin cement system. There is no mention of any software, algorithms, or data processing that would suggest the use of AI or ML.
No
The device is an adhesive resin cement system used for bonding dental restorations, which is generally considered a restorative material or a dental material, not a therapeutic device designed to treat a disease or medical condition.
No
The device description clearly states it is a "light-cure adhesive resin cement system" used for "cementation of ceramic and composite inlays, onlays and laminate veneers". Its function is to bond dental restorations, not to diagnose a condition or disease. The product also includes "Try-in Paste" which "Shade adaptation is available to check by PANAVIA V5 Try-in Paste before cementation", this is not a diagnostic function.
No
The device description clearly states it is a "light-cure adhesive resin cement system" consisting of physical components like paste, primers, and etchant. It also describes physical properties and performance studies related to material characteristics.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "Cementation of ceramic and composite inlays, onlays and laminate veneers with less than 2mm thickness." This describes a dental procedure for bonding restorations to teeth.
- Device Description: The device is described as a "light-cure adhesive resin cement system" used for dental restorations.
- Mechanism of Action: The description focuses on the physical and chemical properties of the cement for bonding, not on analyzing biological samples to diagnose or monitor a medical condition.
- Performance Studies: The performance studies evaluate physical and mechanical properties (according to ISO 4049) and bond strengths, which are relevant to the device's function as a dental cement, not as a diagnostic tool.
IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for the diagnosis, prevention, or treatment of a disease or condition. This device does not fit that description.
N/A
Intended Use / Indications for Use
[1] Cementation of ceramic and composite inlays, onlays and laminate veneers with less than 2mm thickness
Product codes
EMA
Device Description
PANAVIA Veneer LC is a light-cure adhesive resin cement system. It consists of the light-cure cement paste (PANAVIA Veneer LC paste), CLEARFIL CERAMIC PRIMER PLUS, K-ETCHANT Syringe, and PANAVIA V5 Try-in Paste. CLEARFIL Universal Bond Quick or PANAVIA V5 Tooth Primer can be chosen for tooth treatment.
The cement paste is a light-cure, resin based material which provides color stability and has radiopacity equal to or greater than 1mm aluminum. It is indicated for inlays, onlays and laminate veneer restorations made of ceramic and composite resin. It is supplied in Kuraray's ergonomic syringe and dispensed via an angled applicator tip (16G) into an inlay cavity or onto an onlay or a laminate veneer. It is available in 4 shades; Universal (A2), Clear, Brown (A4) and White. It is classified as a Type 2 and Class 2 (Group 1) material by ISO 4049. Shade adaptation is available to check by PANAVIA V5 Try-in Paste before cementation. This is the new registration application for the subject device and there have not been any prior submissions regarding the subject device.
We are seeking clearance for PANAVIA Veneer LC paste in this submission.
Concerning Try-in Paste which is included as components of the PANAVIA V5, CLEARFIL Universal Bond Quick, CLEARFIL CERAMIC PRIMER PLUS and K-ETCHANT Syringe, the specification of those 4 components were omitted for the reasons set forth below.
We already have had 510(k) clearance of Try-in Paste of PANAVIA V5(510(k) Number: 150704), CLEARFIL Universal Bond Quick (510(k) Number: 161042), CLEARFIL CERAMIC PRIMER PLUS (510(k) Number: 150703) and K-ETCHANT Syringe (510(k) Number: 133078).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Tooth
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Physical and mechanical properties of the subject device were evaluated according to ISO 4049: 2009 (Dentistry - Polymer-based restorative and materials).
The results indicate that the subject device and the predicate devices comply with the requirements of ISO 4049: 2009.
The bond strengths to all substrates of the subject device were not statistically (P>0.05) different from that of the primary predicate device.
It was concluded that amount of released fluorine ion from the subject device is substantially equivalent to that of the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Table 5.2.2 Film thickness, luting materials:
§ 872.3275 Dental cement.
(a)
Zinc oxide-eugenol —(1)Identification. Zinc oxide-eugenol is a device composed of zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp.(2)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 872.9.(b)
Dental cement other than zinc oxide-eugenol —(1)Identification. Dental cement other than zinc oxide-eugenol is a device composed of various materials other than zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp.(2)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health and Human Services logo. To the right of that is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
June 11, 2021
Kuraray Noritake Dental Inc. Yasujiro Ohara Manager Ote Center Bldg. 7F, 1-1-3, Otemachi Chiyoda-ku, Tokyo 100-0004 JAPAN
Re: K210504/S001
Trade/Device Name: PANAVIA Veneer LC Regulation Number: 21 CFR 872.3275 Regulation Name: Dental Cement Regulatory Class: Class II Product Code: EMA Dated: April 13, 2021 Received: April 16, 2021
Dear Yasujiro Ohara:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Michael E. Adjodha, M.ChE. Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K210504
Device Name PANAVIA Veneer LC
Indications for Use (Describe)
[1] Cementation of ceramic and composite inlays, onlays and laminate veneers with less than 2mm thickness
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
10th June, 2021 Date:
510(k) Summary: K210504
5-1. 510(k) owner (submitter)
| 1) Name | Kuraray Noritake Dental Inc. |
|---|---|
| 2) Address | 1621 Sakazu, Kurashiki, Okayama 710-0801, Japan |
| 3) Contact person | Yasujiro Ohara |
| Manager | |
| Quality Assurance Department | |
| 4) Contact person in US | Manabu Suzuki |
| Director | |
| Dental Material Division | |
| KURARAY AMERICA, INC. | |
| 33 Maiden Lane, 6th Floor, New York, NY 10038 | |
| Tel: (212)-986-2230 (Ext. 115) or (800)-879-1676 | |
| Fax: (212)-867-3543 | |
| 5-2. Name of Device | |
| 1) Trade / Proprietary name | PANAVIA Veneer LC |
| 2) Classification name | Dental cement |
| (21 CFR section section: 872.3275. Product code: EMA) | |
| 3) Common name | Dental adhesive resin cement |
4
| 5-3. Predicate devices | ||
|---|---|---|
| 1) PANAVIA V5 | ||
| (Primary predicate device) | 510(k) Number: | K150704 |
| Classification: | Dental cement | |
| Product Code: | EMA | |
| 21 CFR Section: | 872.3275 | |
| Applicant: | Kuraray Noritake Dental Inc. | |
| 2) CLEARFIL MAJESTY ES Flow | ||
| (Predicate device) | 510(k) Number: | K191980 |
| Classification: | Tooth shade resin material | |
| Product Code: | EBF | |
| 21 CFR Section: | 872.3690 | |
| Applicant: | Kuraray Noritake Dental Inc. | |
| 3) CLEARFIL Universal Bond | ||
| Quick | ||
| (Reference device) | 510(k) Number: | K161042 |
| Classification: | Resin tooth bonding agent | |
| Product Code: | KLE | |
| 21 CFR Section: | 872.3200 | |
| Applicant: | Kuraray Noritake Dental Inc. | |
| 4) KATANA AVENCIA Block | ||
| (Reference device) | 510(k) Number: | K153476 |
| Classification: | Tooth shade resin material | |
| Product Code: | EBF | |
| 21 CFR Section: | 872.3690 | |
| Applicant: | Kuraray Noritake Dental Inc. |
The relationship between the subject device and each device are shown as follows.
| The Relationship between the subject device and each device are shown as follows: | |
|---|---|
| PANAVIA V5 | |
| (Primary predicate device) | According to ISO 4049: 2009, this predicate device is |
| classified as dual-cure (light-curing and self-curing) | |
| luting material (Type 2 - Class 3 - Group 1). | |
| The subject device is classified as light-curing luting | |
| material (Type 2 - Class 2 - Group 1). Therefore, | |
| The predicate device has the same performance for | |
| light-curing luting material as the subject device. | |
| Intended use and technological characteristics are | |
| almost same as the subject device. | |
| CLEARFIL MAJESTY ES Flow | |
| (Predicate device) | According to ISO 4049: 2009, this predicate device is |
| classified as a Type 2 - Class 2 - Group 1 luting | |
| material when using for cementation as same as the | |
| subject device. | |
| Intended use and technological characteristics for | |
| cementation are almost same as the subject device. | |
| CLEARFIL Universal Bond Quick | |
| (Reference device) | Those devices are chosen to explain the Equivalence |
| of Safety for Chemical Ingredient. | |
| KATANA AVENCIA Block | |
| (Reference device) | And those are the same category (the external |
| communicating device (tissue/ bone/ dentin) and | |
| permanent contact device) as the subject device. |
5-4. Device Description
PANAVIA Veneer LC is a light-cure adhesive resin cement system. It consists of the light-cure cement paste (PANAVIA Veneer LC paste), CLEARFIL CERAMIC PRIMER PLUS, K-ETCHANT Syringe, and PANAVIA V5 Try-in Paste. CLEARFIL Universal Bond Quick or PANAVIA V5 Tooth Primer can be chosen for tooth treatment.
The cement paste is a light-cure, resin based material which provides color stability and has radiopacity equal to or greater than 1mm aluminum. It is indicated for inlays, onlays and laminate veneer restorations made of ceramic and composite resin. It is supplied in Kuraray's ergonomic syringe and dispensed via an
5
angled applicator tip (16G) into an inlay cavity or onto an onlay or a laminate veneer. It is available in 4 shades; Universal (A2), Clear, Brown (A4) and White. It is classified as a Type 2 and Class 2 (Group 1) material by ISO 4049. Shade adaptation is available to check by PANAVIA V5 Try-in Paste before cementation. This is the new registration application for the subject device and there have not been any prior submissions regarding the subject device.
We are seeking clearance for PANAVIA Veneer LC paste in this submission.
Concerning Try-in Paste which is included as components of the PANAVIA V5, CLEARFIL Universal Bond Quick, CLEARFIL CERAMIC PRIMER PLUS and K-ETCHANT Syringe, the specification of those 4 components were omitted for the reasons set forth below.
We already have had 510(k) clearance of Try-in Paste of PANAVIA V5(510(k) Number: 150704), CLEARFIL Universal Bond Quick (510(k) Number: 161042), CLEARFIL CERAMIC PRIMER PLUS (510(k) Number: 150703) and K-ETCHANT Syringe (510(k) Number: 133078).
5-5. Statement of Intended Use
The subject device is indicated for the following uses:
- [1] Cementation of ceramic and composite inlays, onlays and laminate veneers with less than 2mm thickness
6
5-6. Substantial Equivalence Discussion
1) Intended uses
| Trade name | Intended use | |
|---|---|---|
| Subject | ||
| device | PANAVIA Veneer LC | [1] Cementation of ceramic and composite inlays, |
| onlays and laminate veneers with less than 2mm | ||
| thickness | ||
| Predicate | ||
| devices | PANAVIA V5 | |
| (Primary predicate | ||
| device) | [1] Cementation of crowns, bridges, inlays and onlays | |
| [2] Cementation of veneers | ||
| [3] Cementation of adhesion bridges and splints | ||
| [4] Cementation of prosthetic restorations on implant abutments and | ||
| frames | ||
| [5] Cementation of posts and cores | ||
| [6] Amalgam bonding | ||
| Predicate | ||
| devices | CLEARFIL | |
| MAJESTY ES Flow | ||
| (Predicate device) | [1] Direct restorations for all cavity classes, cervical | |
| lesions (e.g. root surface caries, v-shape defects), | ||
| tooth wear, and tooth erosion | ||
| [2] Cavity base / liner | ||
| [3] Correction of tooth position and tooth shape (e.g. | ||
| diastema closure, tooth malformation) | ||
| [4] Intraoral repair of fractured restorations | ||
| [5] Cementation of ceramic and composite inlays, | ||
| onlays and veneers with less than 2mm thickness |
The intended use of the subject device and the predicate devices are listed on the following table.
The intended use of the subject device was written up based on the Intended use [1] and [2] of primary predicate device and the Intended use [5] of Predicate device.
Therefore, the intended use of the subject device is substantially equivalent to those of the predicate devices.
2) Chemical ingredients/ Safety
Except for new ingredients, all ingredients have been used in the predicate devices as described in "Section 12: Substantial Equivalence Discussion". Regarding these predicate devices and reference devices, there have not been any reported problems or recalls according to the post market adverse event reporting requirements in the US.
We evaluated the subject device referring to "Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process" Guidance for Industry and Food and Drug Administration Staff", ISO 10993 series and ISO 7405. As a result of the tests, it was concluded that the subject device is substantially equivalent in biological safety to the predicate devices and reference devices.
-
- Comparison of Technological characteristics/ Effectiveness and Performance Physical and mechanical properties of the subject device were evaluated according to ISO 4049: 2009 (Dentistry - Polymer-based restorative and materials).
7
| Section | Requirement | PANAVIA Veneer LC
(Subject device) | | PANAVIA V5
(Primary
predicate
device) | CLEARFIL
MAJESTY ES
Flow
(Predicate
device) |
|-------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|-----------------------------------|------------------------------------------------|---------------------------------------------------------|
| | | Shade type 1:
Clear
Class 2 | Shade type 2:
White
Class 2 | Shade type:
Universal
(A2)
Class 3 | Class 2 |
| 5.2.2 Film
thickness, luting
materials | 0.05) different from that of the primary predicate device.
Therefore, it was concluded that the bonding performance to all substrates of the subject device was equivalent to that of the predicate device.
Released fluorine ion test was performed to validate the substantial equivalence of the subject device with the primary predicate device.
It was concluded that amount of released fluorine ion from the subject device is substantially equivalent to that of the predicate device.
8
5-7. Biocompatibility
The subject device is categorized into the external communicating device (tissue/ bone/dentin) and permanent contact device. There are new ingredients in the subject device.
Therefore, we evaluated the subject device referring to "Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process" Guidance for Industry and Food and Drug Administration Staff", ISO 10993 series and ISO 7405. The above results led us to the conclusion that the subject device was substantially equivalent in safety to the predicate devices and reference devices.
On the other hand, except for new ingredients on the subject device, all ingredients in the subject device have been used in the predicate device and the reference devices as described in "Section 12: Substantial Equivalence Discussion"
Regarding these the predicate device and the reference devices, there have not been any reported problems or recalls according to the post market adverse event reporting requirements in the US.
Accordingly, it was considered that the subject device was substantially equivalent in safety to the predicate devices and reference devices.
5-8. Conclusion
The comparison for intended uses, chemical ingredients/ safety and performance data shows that the subject device is substantially equivalent to the predicate devices and reference devices. This submission information including the nonclinical testing provided supports that the subject device is as safe and as effective as the predicate devices.